Hinge Health, Inc. (HNGE)
NYSE · Healthcare · Health Information Services
$98.35+0.70%as of Oct 6, 2026, 7:35 AM ET
- Market cap
- $7.9B
- P/E (trailing)
- 32.5
- Forward P/E
- 32.2
- 52-week range
- $30.08 – $99.78
- 52-week change
- +88.99%
- EPS (trailing)
- $3.03
- Analyst rating
- 1.5 Strong buy
- Next earnings
- Nov 2, 2026
Fiscal year to Dec 2025
- Revenue
- $588M (+50.58%)
- Net income
- −$528M
- Operating margin
- −92.9%
- Diluted EPS
- −$7.77
- Free cash flow
- $171M
From the company’s annual report on SEC EDGAR.
About Hinge Health, Inc.
Hinge Health, Inc. focuses on building a health system that scales and automates the delivery of care using technology. It designs its platform to address musculoskeletal system care (MSK), including acute injury, chronic pain, and post-surgical rehabilitation. The company also provides personalized and automated MSK care through AI-powered motion tracking technology and a proprietary electrical nerve stimulation wearable device. It primarily serves self-insured employers. The company was founded in 2012 and is headquartered in San Francisco, California.
Headquarters: San Francisco, United States · 1,437 employees · hingehealth.com